Healthcare
ICON Public Limited Company
ICLRPrice is delayed.
About ICON Public Limited Company
ICON is a clinical research company that helps pharmaceutical and biotechnology firms test new drugs and medical devices. The company manages clinical trials, which are studies that test whether new treatments work and are safe for patients. ICON handles everything from the early stages of drug development through approval by regulators and into the market. They also run laboratories that test blood samples and other materials, and they help companies figure out how to commercialize and sell new treatments once they are approved.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore